Dragon's Blood (Daemonorops draco / Croton lechleri)
What Is Dragon's Blood?
Dragon's Blood is catalogued in the Materia Medica under the binomial Daemonorops draco / Croton lechleri, a plant of the Arecaceae family, native to Southeast Asia. The material in circulation is resin, sap — an exudate pressed or drained from the living tissue. Most people search for it simply as Dragon's Blood; suppliers, pharmacopoeias and interaction databases list it as Daemonorops draco / Croton lechleri, and matching the two is the first step in identifying what is actually in a product. In the hand it reads as sweet, woody-balsamic, deep resinous — a practical marker of freshness and correct identification.
The written history of Dragon's Blood begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the resin, sap contains. Beyond its practical use it carries cultural associations — used in incense for protection and banishing rituals and associated with strength, courage, and ancestral power.
Today most searches for Dragon's Blood come from people reading about wound healing and antibacterial, or checking how it sits alongside a medication they already take. The use most often documented in the literature is proanthocyanidins accelerate wound healing, followed by antimicrobial and hemostatic properties.
How Does Dragon's Blood Work?
Dragon's Blood works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in resin, sap rather than by one marker molecule.
The older understanding of Dragon's Blood is procedural rather than molecular — which part to take, in what season, and in what medium — and modern constituent work has largely been an attempt to explain why those procedures were chosen.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 2 sources. Reported findings centre on small clinical trials support topical wound healing. Where research exists, it examines proanthocyanidins accelerate wound healing, antimicrobial and hemostatic properties and anti-inflammatory taspine content. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into fixed oil and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
What makes Dragon's Blood distinct is the combination rather than any one molecule: the same compound classes appear in other botanicals, but their ratio here — and the resin, sap they are drawn from — is what the traditional and research literature both describe.
Because these constituents are processed by the same pathways that handle many medicines, Dragon's Blood is documented as interacting with anticoagulants. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Dragon's Blood can differ substantially; this is why reference entries specify resin, sap and, where they exist, standardisation markers.